Fig. 8From: The anti-tumor and renoprotection study of E-[c(RGDfK)2]/folic acid co-modified nanostructured lipid carrier loaded with doxorubicin hydrochloride/salvianolic acid AHE staining of the organs (a), Ki67 staining (b), proportion of proliferation (d), TUNEL staining (c) and proportion of apoptosis (e) of the tumor tissues obtained from the tumor-bearing female BALB/c mice treated with different preparations. All the pictures were gained under the magnification of 400×. Scale bar = 50 μm. A: N.S., B: Sal A solution, C: NLC-Sal A, D: DOX solution, E: DOX injection, F: Sal A/DOX solution, G: NLC-DOX, H: NLC-Sal A/DOX, I: E-[c(RGDfK)2]/FA-NLC-Sal A/DOX. **p < 0.01 vs DOX injection, ***p < 0.001 vs DOX injection, △△p < 0.01 vs DOX solution, △△△p < 0.001 vs DOX solution. Results are expressed as mean ± SD, n = 6Back to article page